Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
C&R Research Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩1,957.00 |
52 Week High | ₩2,395.00 |
52 Week Low | ₩1,078.00 |
Beta | 0.14 |
1 Month Change | 60.67% |
3 Month Change | 51.12% |
1 Year Change | 47.81% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -22.95% |
Recent News & Updates
Recent updates
Shareholder Returns
A359090 | KR Life Sciences | KR Market | |
---|---|---|---|
7D | -2.6% | -0.5% | -0.4% |
1Y | 47.8% | 2.2% | 4.5% |
Return vs Industry: A359090 exceeded the KR Life Sciences industry which returned 2.2% over the past year.
Return vs Market: A359090 exceeded the KR Market which returned 4.5% over the past year.
Price Volatility
A359090 volatility | |
---|---|
A359090 Average Weekly Movement | 13.0% |
Life Sciences Industry Average Movement | 7.4% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 11.8% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A359090's share price has been volatile over the past 3 months.
Volatility Over Time: A359090's weekly volatility has increased from 8% to 13% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 483 | Moontae Yoon | www.cnrres.com |
C&R Research Inc. Fundamentals Summary
A359090 fundamental statistics | |
---|---|
Market cap | ₩107.48b |
Earnings (TTM) | ₩5.55b |
Revenue (TTM) | ₩55.10b |
19.4x
P/E Ratio2.0x
P/S RatioIs A359090 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A359090 income statement (TTM) | |
---|---|
Revenue | ₩55.10b |
Cost of Revenue | ₩0 |
Gross Profit | ₩55.10b |
Other Expenses | ₩49.55b |
Earnings | ₩5.55b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 101.04 |
Gross Margin | 100.00% |
Net Profit Margin | 10.07% |
Debt/Equity Ratio | 14.3% |
How did A359090 perform over the long term?
See historical performance and comparison